The HSF1 Knockout UM-UC-3 Polyclonal Cells are a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population originating from the UM-UC-3 human bladder transitional cell carcinoma line, with targeted inactivation of the HSF1 gene. This heterogeneous knockout model enables robust loss-of-function studies of HSF1-dependent transcriptional programs and stress-adaptive responses in bladder cancer, circumventing clonal selection biases inherent to single-cell-derived lines.
UM-UC-3 is a widely employed human urinary bladder transitional cell carcinoma line established from a male patient. It exhibits hallmark invasive properties, anchorage-independent growth, and deregulated oncogenic signaling, making it a relevant model for bladder cancer research. The cell line has been extensively used to investigate tumorigenesis, epithelial?Cmesenchymal transition, and sensitivity to platinum-based chemotherapeutics. Knocking out HSF1 in this context allows dissection of how stress-responsive transcription controls carcinoma aggressiveness and drug tolerance.
HSF1 is the master transcriptional regulator of the heat shock response, activated by proteotoxic, oxidative, and oncogenic stresses through upstream kinases ERK, JNK, p38, AKT, and mTOR. Under basal conditions, monomeric HSF1 is kept inactive via interactions with HSP90AA1 and HSPA1A, and is negatively regulated by HSBP1. Upon stress, HSF1 trimerizes, undergoes hyperphosphorylation, and translocates to the nucleus to bind heat shock elements (HSEs) in target gene promoters. This drives expression of molecular chaperones HSPA1A, HSP90AA1, and HSPB1, co-chaperones DNAJB1 and BAG3, and cytoprotective factors BCL2L1 and CCND1. Additional regulatory interactions involve TPR, DAXX, and acetyltransferase EP300. Signaling integration occurs through components STIP1, MAPK8 (JNK1), and AKT1, which modulate HSF1 activity and connect growth factor and stress signaling to proteostasis.
In bladder cancer, HSF1 supports malignant progression by sustaining protein homeostasis and promoting cell survival under therapeutic and microenvironmental stress. UM-UC-3 cells depend on HSF1 activity to withstand proteotoxic insults from chemotherapeutic agents and to maintain proliferative and migratory abilities. Consequently, HSF1 knockout is expected to impair chaperone induction, sensitize cells to apoptosis, and reduce colony formation and migration, providing a model to study stress-dependent drug resistance mechanisms and the interplay between proteostasis and oncogenic pathways such as MAPK and PI3K/AKT/mTOR.
This polyclonal knockout cell population is amenable to a variety of experimental approaches, including western blotting, RT-qPCR, immunofluorescence, apoptosis and migration assays, colony formation, RNA-seq, and ChIP-qPCR. Researchers can apply these cells to investigate HSF1-dependent gene regulation during drug sensitivity screens, to study stress response dynamics in bladder cancer, or to explore proteostasis network alterations. The model also supports co-culture experiments to probe tumor microenvironment interactions. For further information, please contact Ascent Research.
